Advertisement
Screener

SAREPTA THERAPEUTICS, INC. (SRPT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SAREPTA THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where SAREPTA THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $205.48M went out.
  • Fiscal year ended 2025-12-31: from investing, $69.64M came in.
  • Fiscal year ended 2025-12-31: from financing, $168.34M went out.
  • Fiscal year ended 2025-12-31: change in cash, $304.18M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldOtherNot split outChange in cash
2025-12-31-$205.48M$69.64M-$25.01M$20.00M-$163.33M*-$304.18M
2024-12-31-$205.79M$755.56M$0.00$0.00$0.00$124.81M*$674.58M
2023-12-31-$500.99M-$165.80M$0.00$0.00$0.00$125.00M*-$541.79M
2022-12-31-$325.35M-$1.05B-$25.36M$0.00$0.00$257.87M*-$1.14B
2021-12-31-$443.17M$495.41M$0.00$20.80M$540.77M*$613.81M
2020-12-31$107.47M-$121.72M$0.00$291.15M$312.05M$79.12M*$668.07M
2019-12-31-$456.46M$286.73M$245.63M$365.35M$31.57M*$472.82M
2018-12-31-$388.66M-$370.49M-$3.40M*$513.41M$20.14M*-$229.00M
2017-12-31-$232.00M-$178.81M-$109.00K$30.00M$353.96M$504.23M*$477.27M
2016-12-31-$245.82M-$90.19M-$2.60M$364.80M$15.93M*$42.12M
2015-12-31-$149.47M$8.41M-$2.60M$20.00M$119.92M$10.49M*$6.75M
2014-12-31-$128.54M-$159.03M-$94.00K$94.50M$9.75M*-$183.41M
2013-12-31-$64.69M-$11.67M-$89.00K$123.00M-$226.00K$22.99M*$69.30M
2012-12-31-$29.69M-$1.15M-$85.00K$118.10M$0.00$60.58M*$147.76M
2011-12-31-$23.68M-$2.31M-$81.00K$200.00K$0.00$32.18M*$6.32M
2010-12-31-$15.21M-$1.96M-$77.00K*$2.01M$0.00-$14.69M
2009-12-31-$8.80M-$1.88M-$74.00K$47.84M*$37.08M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backCommercial paperNew shares soldOtherNot split outChange in cash
2026-06-30$197.07M*-$93.37M*$0.00*$0.00*
2026-03-31-$202.68M-$134.39M$0.00*$241.00K-$336.83M
2025-12-31$131.21M*$96.21M*$0.00*$0.00*-$39.21M*
2025-09-30-$14.59M*$232.40M*$0.00*$1.21M*-$119.00M*
2025-06-30$261.34M*$32.21M*$0.00*$1.50M*-$25.32M*
2025-03-31-$583.44M-$291.18M$0.00*$15.68M-$3.21M*-$862.14M
2024-12-31$92.05M*$764.12M*$0.00*$0.00*$48.99M*
2024-09-30-$70.70M*-$128.82M*$0.00*$13.76M*
2024-06-30$14.94M*-$98.53M*$39.92M*
2024-03-31-$242.08M$218.80M$22.14M-$1.14M
2023-12-31-$54.66M*-$64.36M*$0.00*$1.94M*
2023-09-30-$114.71M*-$210.57M*$15.40M*
2023-06-30-$122.23M*$96.63M*$5.86M*
2023-03-31-$209.40M$12.49M$28.04M$73.76M*-$95.11M
2022-12-31-$92.39M*$9.80M*$0.00*$11.30M*-$554.00K*
2022-09-30-$64.96M*$19.12M*$13.41M*$203.02M*
2022-06-30-$66.81M*-$289.99M*$339.00K*
2022-03-31-$101.17M-$785.81M$4.99M-$881.99M
2021-12-31-$29.33M*-$2.58M*$0.00*$2.15M*$547.10M*
2021-09-30-$124.33M*$20.27M*$5.90M*
2021-06-30-$109.15M*$321.06M*$3.53M*
2021-03-31-$180.37M$156.67M$9.23M-$6.33M*-$20.81M
2020-12-31-$174.53M*-$123.89M*$35.83M*$291.11M*
2020-09-30-$238.19M*$54.08M*$18.79M*
2020-06-30-$107.60M*-$34.23M*$21.86M*-$4.29M*
2020-03-31$627.79M-$17.68M$7.48M$311.54M*$929.13M
2019-12-31-$163.79M*$17.08M*$12.03M*$244.94M*
2019-09-30-$67.43M*-$17.96M*$0.00*$1.73M*
2019-06-30-$79.00M*$152.37M*$89.00K*$6.20M*
2019-03-31-$146.23M$135.23M$365.26M$12.30M*$366.56M
2018-12-31-$122.42M*-$237.74M*-$144.00K*$7.19M*$514.24M*
2018-09-30-$113.32M*-$63.40M*$0.00*-$23.95M*
2018-06-30-$117.25M*-$55.09M*$0.00*$25.35M*
2018-03-31-$35.67M-$14.26M-$1.26M$8.74M*-$42.46M
2017-12-31-$31.06M*-$493.69M*-$28.00K*$0.00*$506.84M*
2017-09-30-$57.90M*$124.95M*$4.97M*$377.26M*$449.28M*
2017-06-30-$85.15M*-$20.05M*-$5.01M*$3.84M*-$106.38M*
2017-03-31-$57.89M$209.99M-$43.00K$152.30M
2016-12-31-$81.23M*-$198.77M*$2.47M*-$149.00K*$4.96M*-$272.72M*
2016-09-30-$60.62M*$10.22M*-$2.52M*$327.45M*$8.79M*$283.32M*
2016-06-30-$43.28M*$78.94M*-$26.00K*$38.19M*$73.82M*
2016-03-31-$60.69M$19.42M-$2.52M$1.49M-$42.30M
2015-12-31-$31.27M*-$69.82M*-$25.00K*$125.60M*$24.48M*
2015-09-30-$46.31M*$31.02M*-$2.52M*$4.10M*-$13.72M*
2015-06-30-$28.53M*$3.38M*-$24.00K*$20.27M*-$4.90M*
2015-03-31-$43.35M$43.83M-$25.00K$431.00K$885.00K
2014-12-31-$25.45M*$46.68M*-$24.00K*$21.25M*
2014-09-30-$35.32M*-$20.54M*-$23.00K*$5.43M*-$50.45M*
2014-06-30-$39.50M*-$2.88M*-$24.00K*$96.06M*$53.65M*
2014-03-31-$28.27M-$182.29M-$23.00K$2.71M*-$207.86M
2013-12-31-$17.82M*-$822.00K*-$22.00K*$0.00*-$48.00K*$2.04M*-$16.68M*
2013-09-30-$19.88M*-$1.68M*-$22.00K*$85.10M*$0.00*$53.94M*$117.46M*
2013-06-30-$12.00M*-$1.45M*-$23.00K*$1.74M*-$11.73M*
2013-03-31-$14.99M-$7.72M-$22.00K$2.99M*-$19.74M
2012-12-31-$7.16M*-$423.00K*-$21.00K*$157.28M*$149.67M*
2012-09-30-$7.80M*-$81.00K*$0.00*-$22.00K*$21.40M*$13.50M*
2012-06-30-$5.68M*-$379.00K*$0.00*-$21.00K*-$6.08M*
2012-03-31-$9.05M-$262.00K$0.00-$21.00K-$9.33M
2011-12-31-$5.65M*-$784.00K*-$20.00K*-$6.45M*
2011-09-30-$7.52M*-$320.00K*$0.00*-$21.00K*-$7.83M*
2011-06-30-$442.00K*-$865.00K*$0.00*-$20.00K*$32.23M*$30.91M*
2011-03-31-$10.07M-$336.00K$0.00-$20.00K-$10.31M
2010-12-31-$1.89M*-$507.00K*-$19.00K*-$2.38M*
2010-09-30-$2.77M*-$489.00K*-$19.00K*$2.51M*-$775.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Generate Biomedicines, Inc. (GENB)United States$2.052B
COMPASS Pathways plc (CMPS)$1.812B-4.87
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77